Forebrain Oligodendrocytes Cell
We have developed a novel three-stage protocol that uses only small molecules to make human oligodendrocyte progenitor cells (OPCs) of the forebrain from induced pluripotent stem cells (iPSCs).
Most popular related searches
stem cell ipsc
pluripotent stem cell
drug discovery process
sclerosis ms
cerebral palsy
multiple sclerosis
drug discovery
stem cell
sclerosis cerebral
drug treatment
Published protocols in the scientific literature use proteins and require 50-90 days while we attain OPC commitment in less than ten days.
Oligodendrocytes can be used to accelerate the drug discovery process for treatments of multiple sclerosis (MS), leukodystrophies, cerebral palsy, and Pelizaeus-Merzbacher Disease.